ArticleThe World Allergy Organization journal2023

Revision surgery versus biologic treatment with omalizumab in recurrent chronic rhinosinusitis with nasal polyps: An analysis of cost-utility and clinical outcomes.

Yutong Sima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.